Great news! EverBridge group has reached strategic cooperation with Sinopharm group

On April 12, 2024, EverBridge (Shanghai) Medical Technology Co., Ltd. (hereinafter referred to as "EverBridge group") and Sinopharm Shanghai Medical Devices Co., Ltd. (hereinafter referred to as "Sinopharm Shanghai") launched in-depth cooperation.

At the strategic signing ceremony, the two sides launched in-depth cooperation on multiple production lines of EverBridge group. In the future, the two sides will continue to seek more close and in-depth cooperation to adapt to the changing market demand and policy environment, jointly promote the innovation and progress of China's medical device industry, better serve medical institutions and patients, and promote the whole medical health.

At the signing ceremony, Mr. Xiao Rex, senior vice president of peripheral vascular intervention business of EverBridge group (left), and Mr. Wang Yiran, general manager of Sinopharm Shanghai company (right), signed the strategic cooperation agreement between EverBridge group and Sinopharm Shanghai company. Mr. Lin Rex, marketing director of peripheral vascular intervention business of EverBridge group, Mr. Zhao Ziwei, national sales director of Resonant medical, Mr. Wei Jianxun, deputy general manager of Sinopharm Instruments Shanghai, and Mr. Gong Yinshun, commercial director (from left to right in the back row), attended the event and witnessed the signing ceremony.